Statement Of Cash Flows [Abstract]

Tchaikapharma High Quality Medicines AD - Filing #6023728

Concept	2023-01-01 to 2023-12-31	As at 2023-12-31	As at 2022-12-31	2022-01-01 to 2022-12-31	As at 2021-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Classes of cash receipts from operating activities [abstract]
Receipts from sales of goods and rendering of services	33 521 BGN	—	—	33 019 BGN	—
Classes of cash payments from operating activities [abstract]
Payments to suppliers for goods and services	18 139 BGN	—	—	19 600 BGN	—
Payments to and on behalf of employees	6 580 BGN	—	—	5 433 BGN	—
Other cash payments from operating activities	- BGN	—	—	- BGN	—
Income taxes paid (refund), classified as operating activities	393,000 BGN	—	—	445,000 BGN	—
Other inflows (outflows) of cash, classified as operating activities	5 522 BGN	—	—	5 036 BGN	—
Cash flows from (used in) operating activities	2 864 BGN	—	—	2 461 BGN	—
Cash flows from (used in) investing activities [abstract]
Purchase of other long-term assets, classified as investing activities	1 912 BGN	—	—	1 580 BGN	—
Cash flows from (used in) investing activities	1 912 BGN	—	—	1 580 BGN	—
Cash flows from (used in) financing activities [abstract]
Proceeds from borrowings, classified as financing activities	527,000 BGN	—	—	247,000 BGN	—
Repayments of borrowings, classified as financing activities	527,000 BGN	—	—	248,000 BGN	—
Payments of lease liabilities, classified as financing activities	522,000 BGN	—	—	522,000 BGN	—
Dividends paid, classified as financing activities	499,000 BGN	—	—	273,000 BGN	—
Cash flows from (used in) financing activities	1 021 BGN	—	—	796,000 BGN	—
Increase (decrease) in cash and cash equivalents after effect of exchange rate changes	69,000 BGN	—	—	85,000 BGN	—
Cash and cash equivalents	—	73,000 BGN	142,000 BGN	—	57,000 BGN